Are the effects of the antidepressants amitriptyline, maprotiline, and fluoxetine on inhibitory avoidance state-dependent? 2006

M Carmen Arenas, and Concepción Vinader-Caerols, and Santiago Monleón, and Ana J Martos, and Estrella Everss, and Aránzazu Ferrer-Añó, and Andrés Parra
Department of Psychobiology, University of Valencia, Blasco Ibañez 21, 46010 Valencia, Spain. carmen.arenas@uv.es

State-dependent learning (SDL) is a phenomenon in which the retrieval of newly acquired information is possible if the subject is in the same physiological state as during the encoding phase. SDL makes it possible to separate the effects of drugs per se on learning from the effects due to changes in drug state during the task. The present work was designed to investigate whether the antidepressants amitriptyline (30 mg/kg), maprotiline (25 mg/kg), and fluoxetine (15 mg/kg) produce SDL of the inhibitory avoidance conditioning in male and female CD1 mice. In three separate experiments, independent groups were used for each pharmacological treatment and for each sex using a 2 x 2 experimental design. The results do not show SDL in any of the drugs. In the case of amitriptilyline, the data can be attributed to a memorization deficit, while the maprotiline results are interpreted as simultaneously influenced by memorization deficit and performance facilitation due to motor impairment. Fluoxetine treatment did not produce any deteriorating effect on the conditioning. Drugs had some different effects on the performance of males and females, males showing a slightly higher deterioration than females with administration of amitriptyline and maprotiline. This study shows that these antidepressants affect the acquisition/consolidation but not the retrieval process in the inhibitory avoidance learning.

UI MeSH Term Description Entries
D007266 Inhibition, Psychological The interference with or prevention of a behavioral or verbal response even though the stimulus for that response is present; in psychoanalysis the unconscious restraining of an instinctual process. Inhibition (Psychology),Inhibition, Psychology,Psychological Inhibition,Inhibitions (Psychology),Inhibitions, Psychological,Inhibitions, Psychology,Psychological Inhibitions,Psychology Inhibition,Psychology Inhibitions
D008297 Male Males
D008376 Maprotiline A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use. Ba-34,276,Deprilept,Dibencycladine,Ludiomil,Maprolu,Maprotilin,Maprotilin Holsten,Maprotilin-TEVA,Maprotilin-neuraxpharm,Maprotilin-ratiopharm,Maprotiline Hydrochloride,Maprotiline Mesylate,Mirpan,N-Methyl-9,10-ethanoanthracene-9(10H)-propylamine,Novo-Maprotiline,Psymion,maprotilin von ct,Ba34,276,Hydrochloride, Maprotiline,Maprotilin TEVA,Maprotilin neuraxpharm,Maprotilin ratiopharm,Mesylate, Maprotiline,Novo Maprotiline
D005260 Female Females
D005473 Fluoxetine The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants. Fluoxetin,Fluoxetine Hydrochloride,Lilly-110140,N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine,Prozac,Sarafem,Lilly 110140,Lilly110140
D000639 Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines. Amineurin,Amitrip,Amitriptylin Beta,Amitriptylin Desitin,Amitriptylin RPh,Amitriptylin-Neuraxpharm,Amitriptyline Hydrochloride,Amitrol,Anapsique,Apo-Amitriptyline,Damilen,Domical,Elavil,Endep,Laroxyl,Lentizol,Novoprotect,Saroten,Sarotex,Syneudon,Triptafen,Tryptanol,Tryptine,Tryptizol,Amitriptylin Neuraxpharm,Apo Amitriptyline,Desitin, Amitriptylin,RPh, Amitriptylin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant
D001362 Avoidance Learning A response to a cue that is instrumental in avoiding a noxious experience. Aversion Behavior,Aversion Learning,Aversive Behavior,Aversive Learning,Avoidance Behavior,Aversion Behaviors,Aversive Behaviors,Avoidance Behaviors,Behavior, Aversion,Behavior, Aversive,Behavior, Avoidance,Behaviors, Aversion,Behaviors, Aversive,Behaviors, Avoidance,Learning, Aversion,Learning, Aversive,Learning, Avoidance
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors

Related Publications

M Carmen Arenas, and Concepción Vinader-Caerols, and Santiago Monleón, and Ana J Martos, and Estrella Everss, and Aránzazu Ferrer-Añó, and Andrés Parra
December 2010, Behavioural brain research,
M Carmen Arenas, and Concepción Vinader-Caerols, and Santiago Monleón, and Ana J Martos, and Estrella Everss, and Aránzazu Ferrer-Añó, and Andrés Parra
November 2009, Psicothema,
M Carmen Arenas, and Concepción Vinader-Caerols, and Santiago Monleón, and Ana J Martos, and Estrella Everss, and Aránzazu Ferrer-Añó, and Andrés Parra
May 1988, Acta psychiatrica Scandinavica,
M Carmen Arenas, and Concepción Vinader-Caerols, and Santiago Monleón, and Ana J Martos, and Estrella Everss, and Aránzazu Ferrer-Añó, and Andrés Parra
May 2024, Chemico-biological interactions,
M Carmen Arenas, and Concepción Vinader-Caerols, and Santiago Monleón, and Ana J Martos, and Estrella Everss, and Aránzazu Ferrer-Añó, and Andrés Parra
January 1992, Psychopharmacology,
M Carmen Arenas, and Concepción Vinader-Caerols, and Santiago Monleón, and Ana J Martos, and Estrella Everss, and Aránzazu Ferrer-Añó, and Andrés Parra
July 1974, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
M Carmen Arenas, and Concepción Vinader-Caerols, and Santiago Monleón, and Ana J Martos, and Estrella Everss, and Aránzazu Ferrer-Añó, and Andrés Parra
March 2022, Archives of microbiology,
M Carmen Arenas, and Concepción Vinader-Caerols, and Santiago Monleón, and Ana J Martos, and Estrella Everss, and Aránzazu Ferrer-Añó, and Andrés Parra
September 2004, Alimentary pharmacology & therapeutics,
M Carmen Arenas, and Concepción Vinader-Caerols, and Santiago Monleón, and Ana J Martos, and Estrella Everss, and Aránzazu Ferrer-Añó, and Andrés Parra
January 1978, British journal of clinical pharmacology,
M Carmen Arenas, and Concepción Vinader-Caerols, and Santiago Monleón, and Ana J Martos, and Estrella Everss, and Aránzazu Ferrer-Añó, and Andrés Parra
June 1979, Biological psychiatry,
Copied contents to your clipboard!